Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trial

By Verheugt Freek   Montalescot Gilles   Sabatine Marc   Soulat Louis   Lambert Yves   Lapostolle Frédéric   Adgey Jennifer   Cannon Christopher  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 3, 2007-06 ,pp. : 173-179

Springer Publishing Company

Access to resources Recommend Favorite

Current antiplatelet therapy for Japanese patients with ST elevation acute myocardial infarction: J-AMI registry

By Nakamura Masato  

Cardiovascular Intervention and Therapeutics, Vol. 28, Iss. 2, 2013-04 ,pp. : 162-169

Springer Publishing Company

Access to resources Recommend Favorite

β-blocker therapy after acute myocardial infarction

By Tabrizchi Reza  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 3, 2013-03 ,pp. : 293-296

Informa Healthcare

Access to resources Recommend Favorite

Empiric warfarin dose adjustment with prednisone therapy. A randomized, controlled trial

By Dowd Mary  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 4, 2011-05 ,pp. : 472-477

Springer Publishing Company

Access to resources Recommend Favorite

Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era

By Huikuri H.V.   Tapanainen J.M.   Lindgren K.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 53-54

Elsevier

Access to resources Recommend Favorite